(Q36745377)

English

A single nucleotide polymorphism in the p53 pathway interacts with gender, environmental stresses and tumor genetics to influence cancer in humans

scientific article published on February 2007

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

1 reference

Europe PubMed Central

A single nucleotide polymorphism in the p53 pathway interacts with gender, environmental stresses and tumor genetics to influence cancer in humans (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

single-nucleotide polymorphism

1 reference

based on heuristic

inferred from title

environmental stress

1 reference

based on heuristic

inferred from title

author name string

G L Bond

1

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

A J Levine

2

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

language of work or name

0 references

publication date

1 February 2007

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

26

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

1317-1323

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

The MDM2 promoter polymorphism SNP309T-->G and the risk of uterine leiomyosarcoma, colorectal cancer, and squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210199

21 January 2018

Tumour selection advantage of non-dominant negative P53 mutations in homozygotic MDM2-SNP309 colorectal cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210199

21 January 2018

Mdm2 haplo-insufficiency profoundly inhibits Myc-induced lymphomagenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210199

21 January 2018

A chromatin-associated and transcriptionally inactive p53-Mdm2 complex occurs in mdm2 SNP309 homozygous cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210199

21 January 2018

Multistep carcinogenesis of breast cancer and tumour heterogeneity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210199

21 January 2018

MDM2 SNP309 Accelerates Tumor Formation in a Gender-Specific and Hormone-Dependent Manner

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210199

21 January 2018

A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210199

21 January 2018

A single nucleotide polymorphism in the MDM2 gene: from a molecular and cellular explanation to clinical effect

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210199

21 January 2018

MDM2 is a central node in the p53 pathway: 12 years and counting

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210199

21 January 2018

MDM2 SNP309 accelerates colorectal tumour formation in women.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210199

21 January 2018

Impact of the MDM2 SNP309 and p53 Arg72Pro polymorphism on age of tumour onset in Li-Fraumeni syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210199

21 January 2018

No association of the MDM2 SNP309 polymorphism with risk of breast or ovarian cancer.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210199

21 January 2018

Influence of the MDM2 single nucleotide polymorphism SNP309 on tumour development in BRCA1 mutation carriers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210199

21 January 2018

Genotoxicity of tobacco smoke and tobacco smoke condensate: a review

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210199

21 January 2018

Functions of the MDM2 oncoprotein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210199

21 January 2018

MDM2 induces hyperplasia and premalignant lesions when expressed in the basal layer of the epidermis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210199

21 January 2018

The role of P53 and MDM2 polymorphisms in the risk of esophageal squamous cell carcinoma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210199

21 January 2018

Dissecting p53 tumor suppressor function in vivo through the analysis of genetically modified mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210199

21 January 2018

Overexpression of Mdm2 in mice reveals a p53-independent role for Mdm2 in tumorigenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210199

21 January 2018

Estrogen receptor/Sp1 complexes are required for induction of cad gene expression by 17beta-estradiol in breast cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210199

21 January 2018

Estrogen receptor-dependent proteasomal degradation of the glucocorticoid receptor is coupled to an increase in mdm2 protein expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210199

21 January 2018

Exploiting the p53 pathway for the diagnosis and therapy of human cancer.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210199

21 January 2018

Viral hepatitis and liver cancer: the case of hepatitis C.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210199

21 January 2018

Tumor suppression and normal aging in mice with constitutively high p53 activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210199

21 January 2018

No association between the MDM2 -309 T/G promoter polymorphism and breast cancer in African-Americans or Whites

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210199

21 January 2018

Excess HDM2 impacts cell cycle and apoptosis and has a selective effect on p53-dependent transcription.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210199

21 January 2018

MDM2 promoter polymorphism is associated with both an increased susceptibility to gastric carcinoma and poor prognosis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210199

21 January 2018

The IARC TP53 database: new online mutation analysis and recommendations to users

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210199

21 January 2018

Steroid hormone receptors in breast cancer management

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210199

21 January 2018

MDM2 309T>G polymorphism and risk of lung cancer in a Korean population.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210199

21 January 2018

Differential regulation of the human progesterone receptor gene through an estrogen response element half site and Sp1 sites

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210199

21 January 2018

Somatic mutations in the p53 gene and prognosis in breast cancer: a meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210199

21 January 2018

MDM2 SNP309 and SNP354 are not associated with lung cancer risk.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210199

21 January 2018

Unleashing the power of p53: lessons from mice and men.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210199

21 January 2018

p53 and disease: when the guardian angel fails

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210199

21 January 2018

The single-nucleotide polymorphism 309 in the MDM2 gene contributes to the Li-Fraumeni syndrome and related phenotypes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210199

21 January 2018

Estrogen regulation of vascular endothelial growth factor gene expression in ZR-75 breast cancer cells through interaction of estrogen receptor alpha and SP proteins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210199

21 January 2018

The single nucleotide polymorphism IVS1+309 in mouse double minute 2 does not affect risk of familial breast cancer.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210199

21 January 2018

Genetic polymorphisms in cell cycle regulatory genes MDM2 and TP53 are associated with susceptibility to lung cancer.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210199

21 January 2018

p53 Codon 72 and MDM2 SNP309 Polymorphisms and Age of Colorectal Cancer Onset in Lynch Syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210199

21 January 2018

Association of breast cancer outcome with status of p53 and MDM2 SNP309

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210199

7 January 2021

based on heuristic

inferred from DOI database lookup

MDM2 promoter SNP309 is associated with the risk of hepatocellular carcinoma in patients with chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210199

7 January 2021

based on heuristic

inferred from DOI database lookup

Estrogen receptor (ER) and progesterone receptor (PgR), by ligand-binding assay compared with ER, PgR and pS2, by immuno-histochemistry in predicting response to tamoxifen in metastatic breast cancer: a Southwest Oncology Group Study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210199

7 January 2021

based on heuristic

inferred from DOI database lookup

Genetic variants in the MDM2 promoter and lung cancer risk in a Chinese population

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210199

7 January 2021

based on heuristic

inferred from DOI database lookup

MDM2 gene promoter polymorphisms and risk of lung cancer: a case-control analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210199

7 January 2021

based on heuristic

inferred from DOI database lookup

Association of a functional polymorphism in the promoter of the MDM2 gene with risk of nonsmall cell lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210199

7 January 2021

based on heuristic

inferred from DOI database lookup

Targeted expression of MDM2 uncouples S phase from mitosis and inhibits mammary gland development independent of p53.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210199

7 January 2021

based on heuristic

inferred from DOI database lookup

Polymorphisms in the MDM2 promoter and risk of breast cancer: a case-control analysis in a Chinese population

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210199

7 January 2021

based on heuristic

inferred from DOI database lookup

mdm2 gene alterations and mdm2 protein expression in breast carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210199

7 January 2021

based on heuristic

inferred from DOI database lookup

Association between MDM2-SNP309 and age at colorectal cancer diagnosis according to p53 mutation status.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210199

7 January 2021

based on heuristic

inferred from DOI database lookup

MDM2 promoter variation and age of diagnosis of acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210199

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.ONC.1210199

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36745377&oldid=2199265393"